Table of Contents
International Journal of Molecular Imaging
Volume 2016, Article ID 6045894, 5 pages
http://dx.doi.org/10.1155/2016/6045894
Research Article

A Pilot Study of 18F-FLT PET/CT in Pediatric Lymphoma

1Department of Medical Imaging, University of Toronto, 263 McCaul Street, 4th Floor, Toronto, ON, Canada M5T 1W7
2Department of Diagnostic Imaging, Hospital for Sick Children, 555 University Avenue, Toronto, ON, Canada M5G 1X8
3Department of Pediatrics, Hospital for Sick Children, 555 University Avenue, Toronto, ON, Canada M5G 1X8

Received 15 December 2015; Accepted 5 May 2016

Academic Editor: J. M. Mountz

Copyright © 2016 Danny L. Costantini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. R. Bading and A. F. Shields, “Imaging of cell proliferation: status and prospects,” Journal of Nuclear Medicine, vol. 49, supplement 2, pp. 64S–80S, 2008. View at Publisher · View at Google Scholar
  2. A. F. Shields, “Positron emission tomography measurement of tumor metabolism and growth: its expanding role in oncology,” Molecular Imaging and Biology, vol. 8, no. 3, pp. 141–150, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. F. Shields, J. R. Grierson, B. M. Dohmen et al., “Imaging proliferation in vivo with [F-18]FLT and positron emission tomography,” Nature Medicine, vol. 4, no. 11, pp. 1334–1336, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. S. J. Choi, J. S. Kim, J. H. Kim et al., “[18F]3′-deoxy-3′-fluorothymidine PET for the diagnosis and grading of brain tumors,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 32, no. 6, pp. 653–659, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Gilles, W. V. Vogel, C. E. M. Gidding, G. O. R. J. Janssens, T. M. Van Der Vliet, and W. J. G. Oyen, “18F-fluoro-L-thymidine-PET for the evaluation of primary brain tumours in children: a report of three cases,” Nuclear Medicine Communications, vol. 31, no. 6, pp. 482–487, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Hatakeyama, N. Kawai, Y. Nishiyama et al., “11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 35, no. 11, pp. 2009–2017, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Saga, H. Kawashima, N. Araki et al., “Evaluation of primary brain tumors with FLT-PET: usefulness and limitations,” Clinical Nuclear Medicine, vol. 31, no. 12, pp. 774–780, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Tripathi, R. Sharma, M. D'Souza et al., “Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas,” Clinical Nuclear Medicine, vol. 34, no. 12, pp. 878–883, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. D. L. Costantini, R. Vali, J. Chan, S. McQuattie, and M. Charron, “Dual-time-point FDG PET/CT for the evaluation of pediatric tumors,” American Journal of Roentgenology, vol. 200, no. 2, pp. 408–413, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Vesselle, J. Grierson, L. M. Peterson, M. Muzi, D. A. Mankoff, and K. A. Krohn, “18F-fluorothymidine radiation dosimetry in human PET imaging studies,” Journal of Nuclear Medicine, vol. 44, no. 9, pp. 1482–1488, 2003. View at Google Scholar · View at Scopus
  11. D. Delbeke, S. Stroobants, E. de Kerviler, C. Gisselbrecht, M. Meignan, and P. S. Conti, “Expert opinions on positron emission tomography and computed tomography imaging in lymphoma,” The Oncologist, vol. 14, supplement 2, pp. 30–40, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Elstrom, L. Guan, G. Baker et al., “Utility of FDG-PET scanning in lymphoma by WHO classification,” Blood, vol. 101, no. 10, pp. 3875–3876, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Manohar, B. R. Mittal, S. Raja, A. Bhattacharya, P. Malhotra, and S. Varma, “Comparison of various criteria in interpreting end of therapy F-18 labeled fluorodeoxyglucose positron emission tomography/computed tomography in patients with aggressive non-Hodgkin lymphoma,” Leukemia and Lymphoma, vol. 54, no. 4, pp. 714–719, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Shammas, R. Lim, and M. Charron, “Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions,” Radiographics, vol. 29, no. 5, pp. 1467–1486, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Gallamini, S. F. Barrington, A. Biggi et al., “The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale,” Haematologica, vol. 99, no. 6, pp. 1107–1113, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Barwick, B. Bencherif, J. M. Mountz, and N. Avril, “Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation,” Nuclear Medicine Communications, vol. 30, no. 12, pp. 908–917, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Charron, Practical Pediatric PET Imaging, Springer, New York, NY, USA, 2006.
  18. A. Salskov, V. S. Tammisetti, J. Grierson, and H. Vesselle, “FLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3′-Deoxy-3′-[18F]fluorothymidine,” Seminars in Nuclear Medicine, vol. 37, no. 6, pp. 429–439, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. E. G. C. Troost, W. V. Vogel, M. A. W. Merkx et al., “18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients,” Journal of Nuclear Medicine, vol. 48, no. 5, pp. 726–735, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. A. K. Buck, M. Bommer, S. Stilgenbauer et al., “Molecular imaging of proliferation in malignant lymphoma,” Cancer Research, vol. 66, no. 22, pp. 11055–11061, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Schöder, A. Noy, M. Gönen et al., “Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma,” Journal of Clinical Oncology, vol. 23, no. 21, pp. 4643–4651, 2005. View at Publisher · View at Google Scholar · View at Scopus